<DOC>
	<DOCNO>NCT00815594</DOCNO>
	<brief_summary>The occurrence conjunctival scar finally lead obstruction fistula tract create filter surgery . Vascular endothelial growth factor think key role formation conjunctival scar , play pivotal role wound-healing process . So seem recombinant human anti-VEGF antibody could inhibit angiogenesis , reduce conjunctival vascular formation wound-healing process glaucoma filter surgery .</brief_summary>
	<brief_title>Bleb Vascularity Change After Subconjunctival Injection Bevacizumab</brief_title>
	<detailed_description />
	<mesh_term>Cicatrix</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Glaucoma patient trabeculectomy whose bleb hyperaemia Affected eye normal IOP Not allergic Avastin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>bleb</keyword>
	<keyword>vascular change</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>trabeculectomy</keyword>
	<keyword>Bleb vascularity associate increase scarring activity</keyword>
	<keyword>Conjunctival scar finally lead obstruction fistula tract create filtering surgery</keyword>
	<keyword>recombinant human anti-VEGF antibody could inhibit angiogenesis conjunctiva .</keyword>
</DOC>